氧化磷酸化
糖酵解
运输机
氨基酸
生物化学
谷氨酰胺
代谢组学
下调和上调
生物
代谢途径
代谢工程
化学
计算生物学
细胞生物学
溶质载体族
新陈代谢
仿形(计算机编程)
细胞因子
转录组
基因表达谱
磷酸化
葡萄糖转运蛋白
氨基酸代谢
生物信息学
癌症研究
代谢组
白血病
作者
Naomi N. Taylor,Josquin Moraly,Taisuke Kondo,King C. Chan,Sooraj R. Achar,Makoto Ando,Marie Pouzolles,Bonnie Yates,Alexandra Dreyzin,Mehdi Benzaoui,Alka Dwivedi,Saliha Majdoul,Justin M. Mirazee,Jaehyun Suh,Angela Su,Cédric Mongellaz,Hannah Dada,Swapna Vidhur Daulatabad,Krithikha Bhuvaneshwar,Mina O. Seedhom
出处
期刊:Research Square
日期:2026-09-15
标识
DOI:10.21203/rs.3.rs-10832865/v1
摘要
Abstract CAR T-cell efficacy requires post-infusion expansion and persistence, yet metabolic programs supporting T-cells in patients remain poorly defined. Here, we developed a high-throughput single-cell immunometabolic profiling pipeline and applied it across pediatric leukemia trials, revealing a conserved post-infusion CAR T-cell shift from glycolysis toward amino acid-driven oxidative phosphorylation (OXPHOS). Within this remodeling, OXPHOS-dependent stem-like CAR T-cell subsets were enriched in patients achieving complete remission. Longitudinal plasma metabolomics revealed cytokine release syndrome-associated depletion of multiple amino acids, including glutamine and arginine, during CAR T-cell expansion, creating a nutrient-restricted environment. Analysis of public CAR T-cell datasets showed that responders upregulated amino-acid solute carrier transporters, whereas disrupting uptake impaired translation, OXPHOS, stemness, and cytotoxicity. Guided by these findings, we screened amino-acid transporters for CAR T-cell engineering. SLC1A5-, SLC7A1-, and SLC38A9-armored CAR T-cells emerged as the most promising, with enhanced oxidative capacity and anti-leukemic efficacy, establishing amino acid transport as a targetable metabolic checkpoint.
科研通智能强力驱动
Strongly Powered by AbleSci AI